4D Molecular Therapeutics, Inc. - COM (FDMT)

Historical Institutional Holders from Q4 2020 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Equity / COM
Shares, excl. options Q4 2024
46.8M
Holdings value Q4 2024
$261M
Value change Q4 2024
-$77.7M
Grand Portfolio weight change Q4 2024
0%
Number of holders
138
Number of buys Q4 2024
72
Number of sells Q4 2024
-70
Average buys Q4 2024 %
+0%
Average sells Q4 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 46.8M $261M -$77.7M $5.57 137
2024 Q3 57.7M $623M -$37.5M $10.81 134
2024 Q2 57.3M $1.2B +$3.26M $20.99 139
2024 Q1 56.3M $1.79B +$451M $31.86 148
2023 Q4 42.4M $860M +$24.8M $20.26 112
2023 Q3 41.9M $534M +$5.22M $12.73 110
2023 Q2 41.2M $745M +$197M $18.07 100
2023 Q1 30.4M $522M +$35M $17.19 94
2022 Q4 28M $622M +$47.7M $22.21 97
2022 Q3 26.2M $210M +$1.97M $8.04 83
2022 Q2 26M $182M -$2.17M $6.98 86
2022 Q1 26.1M $395M +$20.4M $15.12 76
2021 Q4 24.7M $542M +$81.1M $21.94 77
2021 Q3 18.7M $505M +$57.5M $26.97 61
2021 Q2 16.6M $400M +$732K $24.08 54
2021 Q1 15.4M $665M +$34.1M $43.38 63
2020 Q4 14.6M $602M +$578M $41.45 51